Part number: MN-1243-G
Image is representative (may not be specific item).
Download: Quick guide translations - hemaPEN [PDF]
Languages:
Also see: Quick guide - hemaPEN
Also see: Instructions for use - hemaPEN
Also see: Video - Instructional video for hemaPEN use
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
Collections: All, French, hemaPEN, hemaPEN (all), Instructions for use, Literature - All, Literature - Health, Microsampling, Sampling, Support Items
Category: ARTG, ARTG 280007, Australia, Australian Register of Therapeutic Goods, Blood, Bulgarian, CE mark, Class I, Clinical, Croatian, Czech, Danish, DBS, Dutch, Estonian, EU, FDA, French, German, Greek, Health, hemaPEN, Histology, Hungarian, IFU, Italian, IVD, Latvian, Life, Lithuanian, MHRA 64872, Microsampling, New Zealand, Norwegian, Pathology, Polish, Portuguese, Research, Romanian, Sample collection, Sampling, Slovak, Slovene, Spanish, Support, Swedish, TGA, Therapeutic Goods Administration, UK, US FDA, US FDA D410490, USA
Type: Instructions for use
Download: Advanced precision microsampling for COVID-19 research [PDF]
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Download: Application Note - Analysis of 15 organic acids [PDF]
Download: Application Note - Analysis of 16 synthetic pyrethroids [PDF]
Download: Application Note - Analysis of 16 synthetic pyrethroids [PDF]
Privacy and security | Terms and conditions
© 2023 Trajan Scientific and Medical. Trajan Scientific Australia Pty Ltd.